In the BioHarmony Drug Report Database
Neptazane (methazolamide) is a small molecule pharmaceutical. Methazolamide was first approved as Neptazane on 1982-01-01. It is used to treat angle-closure glaucoma and open-angle glaucoma in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 4, carbonic anhydrase 14, carbonic anhydrase 1, and carbonic anhydrase 12.
Image (chem structure or protein)